Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMPT: Topiramate in Prolonged Migraine Prevention
NCT00216619Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 20
01
Overview
Phase 3, randomised, double-blind trial of topiramate in migraine (3 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Change in migraine days at 26 weeks. Started Nov 2003; status: completed.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00216619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216619.